May Young Lin

May Young Lin has worked in the pharmaceutical and medical industries since 2000. May Young began their career as an intern at Rijksuniversiteit Groningen in 2000, where they worked on a project measuring T cell functions. In 2001, they were an intern at the University Medical Centre Groningen, where they studied and characterized the expression of a receptor involved in multiple sclerosis. In 2003, they became a PhD student at Leiden University Medical Center, where they worked in the Immunology (infectious diseases) department. In 2009, they became a Post Doc at Universiteit Utrecht, where they worked on a project involving the design, setup, and performance of experiments in the field of molecular and cellular immunobiology. In 2012, they became a Project Leader in Pharmaceutical Technologies at FeyeCon Carbon Dioxide Technologies. In 2015, they joined Echo Pharmaceuticals as a Clinical Research and Pharmaceutical Manager. Finally, in 2018, they joined ISA Pharmaceuticals as a Senior Scientist Immunomonitoring, Supply Chain Project Manager, and CMC Coordinator.

May Young Lin attended Praedinius Gymnasium from 1991 to 1997 and then went on to pursue a MSc. in Medical Biology at the University of Groningen from 1997 to 2002.